Core Molding Technologies

CMT

Market cap $198M

COLUMBUS, Ohio, July 14, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty trucks, powersports, building products, and industrial and utility industries across North America, today announces that it will release its second quarter fiscal 2026 results on Tuesday, August 4, 2026, before the market opens. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet the same day at 10:00am Eastern.

COLUMBUS, Ohio, July 07, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in medium- and heavy-duty truck, powersports, building products, and industrial and utility industries across the United States, Canada, and Mexico, today announced the successful amendment and extension of its credit agreement through 2031. The amended credit facility consists of a $50 million delayed draw term loan and a $50 million revolving credit facility.

Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore skeletal muscle health, today announces that further safety and efficacy data from its Phase 2a SYNAPSE-CMT exploratory study evaluating ignaseclant in patients living with Charcot-Marie-Tooth disease (CMT) types 1 or 2 has been presented in a late-breaking oral presentation at the 2026 Peripheral Neuroscience Association (PNS) Annual Meeting held in Maastricht, The Netherlands from June 13-16, 2026. The late-breaking presentation was given by David Herrmann, MD, Chief of the Neuromuscular Division and Vice Chair for Strategic Initiatives in the Department of Neurology at the University of Rochester Medical Center on Sunday, June 14, 2026.

Core Molding Technologies reported 1Q26 results showing pressured trucking revenues offset by strength in industrial, EV, and BESS segments. CMT maintains robust gross margins (~20%) and expects 17–19% for the year, with adjusted operating income potentially reaching $20 million in 2026. Management anticipates a trucking cycle recovery and sales upside from the expanded Matamoros facility in 2H26, but near-term revenue growth remains muted.

Small caps are finally getting their moment. The iShares Russell 2000 ETF (NYSEARCA:IWM | IWM Price Prediction) is up 12.11% year to date and 31.51% over the past year, a sharp rotation away from the mega-cap trade that dominated the prior cycle.

COLUMBUS, Ohio, May 14, 2026 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding,” “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today announced that management will participate in the 16th Annual East Coast IDEAS Investor Conference at The Westin New York at Times Square. The Company will host one-on-one investor meetings throughout the day, with their presentation scheduled for 3:20-3:55 PM ET on June 10th.

Core Molding Technologies, Inc. (CMT) Q1 2026 Earnings Call Transcript

Core Molding Technologies (CMT) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.25 per share a year ago.

First Quarter Delivers New Wins of $17 million, Margin Expansion, Strategic Investment Progress, and Early Signs of Cycle Recovery First Quarter Delivers New Wins of $17 million, Margin Expansion, Strategic Investment Progress, and Early Signs of Cycle Recovery

Core Molding Technologies (CMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.